Last reviewed · How we verify
Zegerid
At a glance
| Generic name | Zegerid |
|---|---|
| Also known as | omeprazole/sodium bicarbonate, SCH 900934 |
| Sponsor | Bayer |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma (PHASE2)
- A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) (PHASE2)
- Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill (PHASE3)
- Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets (PHASE1)
- A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects (PHASE1)
- A Unique Regimen for Treatment of Helicobacter Pylori Infection (PHASE3)
- Management of Myocardial Injury After Noncardiac Surgery Trial (PHASE3)
- Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |